Creso Pharma |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 7:13pm | ||||
|
Market Cap (14-Nov) $23,106,150 (942nd) |
Close (13-Jun) $0.009 |
Volume (13-Jun) 0 |
Shortsold (8-Jun) 1,624,075 (0.07%) (501st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
Appendix 2A
CPH released this announcement to the ASX on 12 February 2021, 17:44. The announcement is not marked as price sensitive, and is 15 page(s) in length and 311.48kb in size.
You can view all announcements from CPH and see how they appear on a price chart on the announcements page.
At the date of this announcement, CPH was 0.017% short sold according to ASIC data. It was ranked the 530th most shorted stock on the ASX. It is now ranked as the 501st most shorted stock on the ASX with 0.066% of total shares short sold as of the latest reported data (08 June 2023).
| Other Recent Announcements from CPH | |
|---|---|
| Notification regarding unquoted securities - CPH | 9 June 2023, 16:23 |
| LOI to Import MDMA & Psilocybin Treatments to Australia | 9 June 2023, 9:42 |
| Application for quotation of securities - CPH | 8 June 2023, 18:23 |
| Appendix 2A | 12 February 2021, 17:44 |
| Creso brings cannaqix sales inhouse to improve margins | 8 February 2021, 9:17 |
| Secondary Trading Notice & Appendix 2A | 5 February 2021, 19:26 |
| New POs demonstrate patient uptake | 3 February 2021, 8:16 |
If you were already registered, log in here.